RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Clinical trials for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug BL-M11D1 takes aim at tough leukemia in early trial
Disease control Recruiting nowThis early-phase trial is testing a new drug called BL-M11D1 in 120 adults with acute myeloid leukemia that has come back or not responded to standard treatments. The drug is designed to target and deliver a toxin directly to leukemia cells. The main goals are to check safety, fi…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Experimental CAR-T therapy takes on tough leukemia
Disease control Recruiting nowThis early-stage trial is testing a new type of CAR-T cell therapy, called CT0890B, for people with acute myeloid leukemia (AML) that has come back or not responded to treatment. The therapy uses donor-derived immune cells that are engineered to target a protein called NKG2DL on …
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Immune cells engineered to hunt cancer: new trial for hard-to-treat blood cancers
Disease control Recruiting nowThis early-phase trial tests a new cell therapy for people with T-cell lymphoma or acute myeloid leukemia that has come back or not responded to standard treatments. The therapy uses immune cells (NK cells) from donated cord blood that are engineered to recognize and attack cance…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New drug cocktail aims to beat back tough leukemia
Disease control Recruiting nowThis Phase 2 trial tests whether adding venetoclax to a five-drug regimen (CACAG) works better than standard treatments for people whose acute myeloid leukemia has returned or not responded. About 200 adults aged 14 to 75 will be randomly assigned to one of the two approaches. Th…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New hope for tough leukemia: experimental drug targets resistant cancers
Disease control Recruiting nowThis study tests a new drug, NMS-03597812, in adults with acute myeloid leukemia that has come back or not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink or control the cancer. About 124 people will take part, including those with…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for kids with tough leukemia: drug combo trial launches
Disease control Recruiting nowThis early-phase trial tests a combination of two chemotherapy drugs—Vyxeos (a liposomal form of daunorubicin and cytarabine) and clofarabine—in 25 children and young adults (ages 1-21) with relapsed or refractory acute myeloid leukemia (AML). The main goal is to find the safest …
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Jun 26, 2026 13:49 UTC
-
Can lab tests guide better AML treatment choices?
Knowledge-focused Recruiting nowThis study explores whether combining a drug sensitivity test with detailed genetic profiling can help doctors recommend the best treatment for each patient with relapsed or refractory acute myeloid leukemia (AML). Researchers will take extra blood or bone marrow samples from 18 …
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC